Drug Discovery and Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
AbbVie, EvolveImmune Partner to Develop Next-Gen Cancer Biotherapeutics
Will leverage EvolveImmune's EVOLVE T-Cell Engager Platform to develop multispecific therapeutic antibodies for cancer.11.01.24
-
Analytical Services | Breaking News | cGMP Manufacture | Drug Development | Fill/Finish | Formulation Development | Industry News
FDA Approves McGuff Pharmaceuticals Facility in Santa Ana, CA
The 86,000-sq.-ft. sterile fill-and-finish manufacturing plant creates new business opportunities in both the CMO and CDMO markets.10.31.24
-
Capsules | Formulation Development | Injectables
-
Breaking News | Industry News | Laboratory Testing
Navigate BioPharma Services Earns CAP Accreditation
Based on ISO 15189 Standard for laboratories' technical competence, management, and continual improvement.10.31.24
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Sterling Pharma Solutions Expands GMP ADC Manufacturing Capacity
A new 2,300-sq.-ft. suite at Deeside, UK site will allow clinical-scale manufacturing using reactors up to 500 liters, doubling the site’s capacity10.30.24
-
Breaking News | Clinical Trials | CRO News | Information Technology
AMR Deploys Advarra’s Site Training and Engagement Platform
Network of 30+ Clinical Research Centers aims to improve staff experience and accelerate study startup.10.30.24
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Microbiology | QA/QC
Abzena to Expand Microbiology Lab Space to Support Biologic Manufacturing
Enhances analytical services for antibodies with rapid microbiology release testing and improved scalability through advanced materials separation.10.30.24
-
Analytical Services | Breaking News | Collaborations & Alliances
Jubilant Radiopharma & Simplified Imaging Solutions Partner to Streamline Nuclear Medicine
Will jointly offer a one-stop shop for nuclear medicine needs.10.30.24
-
Breaking News | Clinical Trials
Biond Biologics, Merck KGaA Collaborate on Phase 1 Trial for Solid Tumors
Merck KGaA will supply Biond Biologics with cetuximab to support its clinical trial.10.30.24
-
Breaking News | Drug Discovery | Industry News
Kapoose Creek Bio Acquires Adapsyn's AI Platform and Talent
Together the companies’ platforms will create an end-to-end bespoke solution for natural product drug discovery.10.30.24
-
Breaking News | Industry News | R&D
PharmaLogic Opens Los Angeles Radiopharmaceutical Facility
Renovated production and lab space will enable PharmaLogic to scale up current production, as well as channel significant resources towards R&D.10.29.24
-
Breaking News | Collaborations & Alliances | Drug Development
Monte Rosa, Novartis Partner to Advance Molecular Glue Degraders
Aims to accelerate MRT-6160 clinical development and explore therapeutic opportunities across multiple indications.10.29.24
-
Breaking News | Collaborations & Alliances | Drug Delivery
Ryvu and nCage Partner to Develop Next-Generation ADC Platform
Aim to develop a novel drug delivery system (DDS) that could improve the efficacy and safety of current ADCs.10.29.24
-
Breaking News | Drug Development | Industry News
AbbVie to Acquire Aliada Therapeutics for $1.4B
Aliada's lead compound is an anti-pyroglutamate amyloid beta antibody, a potential best-in-class therapy for Alzheimer's disease.10.29.24
-
Biologics, Proteins, Vaccines | Breaking News
Naobios and Sumagen Achieve Milestone in HIV-1 Vaccine Production
Successfully optimize HIV vaccine candidate for industrial production.10.29.24
-
Bioanalytical Services | Breaking News | Facilities
Ardena Expands Bioanalytical Services in the Netherlands
Investment includes establishing a new bioanalytical lab in Oss, along with additional capacity and new GLP capabilities in Assen.10.29.24
-
Breaking News | Clinical Trials
MMV, Quotient Sciences Initiate Trial for Long-Acting Malaria Preventive
MMV371 is being developed as a single-dose intramuscular injection that could provide up to three months of protection against malaria.10.28.24
-
Breaking News | Collaborations & Alliances | R&D
GC Biopharma Partners with Novelty Nobility to Develop GA Treatment
Aim to fulfill an unmet need for therapeutic approaches with improved efficacy and safety for GA patients.10.28.24
-
Chemistry | Extractables and Leachables | Microbiology
-
Biologics, Proteins, Vaccines | Breaking News
LakeShore Biopharma's YSJA Rabies Vaccine Heads to Phase III Trial
Will explore the immunogenicity and safety of a simplified four-dose regimen for the rabies vaccine.10.25.24
